What the Research Says
Elderberry has demonstrated potential benefits for respiratory health and immune support, as supported by clinical studies. A meta-analysis by Hawkins et al. (2019) involving 180 participants across multiple randomized controlled trials found that black elderberry supplementation significantly reduced the duration and severity of upper respiratory symptoms. This aligns with findings from Tiralongo et al. (2016), who conducted a double-blind, placebo-controlled trial with 312 air travelers and observed that elderberry supplementation notably decreased cold duration and symptom severity in those who fell ill.
The antiviral properties of elderberry have been explored in mechanistic studies. Roschek et al. (2009) identified that elderberry flavonoids can bind to influenza virus proteins, thereby inhibiting viral entry into host cells. This suggests a plausible mechanism for its observed effects on respiratory infections.
However, the evidence base for elderberry is relatively limited compared to other immune-supporting supplements like vitamin C or zinc. A systematic review by Wieland et al. (2021) highlighted that while elderberry may reduce cold and influenza duration and severity, the evidence remains uncertain due to the small number of trials and variability in study designs. Additionally, a broader systematic review by Crawford et al. (2022) of 39 studies on various dietary supplements, including elderberry, found limited support for its efficacy in preserving immune health under stressors.
Overall, while elderberry shows promise for managing respiratory infections, further research is needed to confirm its benefits and establish optimal dosing and usage guidelines.
